Page 27 - Terminology-Clinical-Research
P. 27

for the endpoint event being described is not constant with   HRPP: Human Research Protection Program.
        respect to time.
                                                               HSR: Human Subjects Research.
        Health authority: A national or international health
        organization that has authority over a clinical study. Note:   Human pharmacology (Phase I): Human pharmacology
        Used in the European Union.                            (Phase I) trials are the first stage of testing in human
                                                               subjects, generally comprising a small group of healthy
        Health Level 7 (HL7): An ANSI-accredited Standards     volunteers. This phase includes trials designed to assess the
        Developing Organization (SDO) operating in the         safety (pharmacovigilance), tolerability, pharmacokinetics,
        healthcare arena. Note: Level 7 refers to the highest   and pharmacodynamics of a drug.
        level of the International Standards Organization’s (ISO)
        communications model for Open Systems Interconnection   Human subject: Individual who is or becomes a
        (OSI), the application level. The application level addresses   participant in research, either as a recipient of the test
        definition of the data to be exchanged, the timing of the   article or as a control. A subject may be either a healthy
        interchange, and the communication of certain errors to   human or a patient.
        the application. Level 7 supports such functions as security
        checks, participant identification, availability checks,   Human subjects review board: A group of people who
                                                               review, approve, and monitor the clinical study protocol.
        exchange mechanism negotiations, and, most importantly,   Their role is to protect the rights and welfare of human
        data exchange structuring.
                                                               research subjects participating in a study. The group
        Healthcare provider: 1. One who directly or indirectly   typically includes people with varying backgrounds,
        administers interventions that are designed to improve   including a community member, to make sure that research
        the physical or emotional status of patients. 2. A person   activities conducted by an organization are completely and
        licensed, certified, or otherwise authorized or permitted   adequately reviewed. Also known as an institutional review
        by law to administer healthcare in the ordinary course of   board (IRB) or ethics committee.
        business or practice of a profession, including a healthcare
        facility.                                              Huriet Law: France’s regulations covering the initiation
                                                               and conduct of clinical trials.
        Healthy volunteer: Subject (not a patient) in a clinical   HyperText Markup Language (HTML): A specification
        trial. Note: Usually healthy volunteers serve as subjects in   of the W3C that provides markup of documents for display
        Phase 1 trials.
                                                               in a web browser.
        Herbal medicinal product: Any medicinal product
        exclusively containing as active ingredients one or more   Hypertext: Links in a document that permit browsers to
        herbal substances or preparations. Adapted from Dir    jump immediately to another document. Note: In most
                                                               browsers links are displayed as colored, underlined text.
        83/2001.
                                                               Hypothesis to test: In a trial, a statement relating to the
        HIPAA: The Health Insurance Portability and
        Accountability Act of 1996 (HIPAA) established national   possible different effect of the interventions on an outcome.
        standards for electronic health care transactions and   The null hypothesis of no such effect is amenable to
        national identifiers for providers, health plans, and   explicit statistical evaluation by a hypothesis test, which
                                                               generates a P value.
        employers. It also addresses the security and privacy of
        health data. All clinical trial data and activities performed   Hypothesis: A theory, supposition or assumption advanced
        by covered entities must comply with HIPAA regulations.  as a basis for reasoning or argument, or as a guide to
                                                               experimental investigation.
        Holders (award): Undergraduate and graduate students
        and postdoctoral fellows supported by CIHR through
        scholarships or fellowships; or researchers supported by
        salary or career support grants from CIHR.                                       I

        Homeopathic medicinal product: Homeopathic medicinal
        products are medicinal products based on a dilute
        solution of raw material from the plant, animal or mineral
        kingdoms.                                              IDE: Investigational Device Exemption.



                                             TERMINOLOGY CLINICAL RESEARCH                                        27
   22   23   24   25   26   27   28   29   30   31   32